Cita APA

Zhou, J., Le, K., Xu, M., Ming, J., Yang, W., Zhang, Q., . . . Huang, T. (2020). CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation. Mol Ther Oncolytics.

Citación estilo Chicago

Zhou, Jun, et al. "CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer Via Inhibiting AKT Phosphorylation." Mol Ther Oncolytics 2020.

Cita MLA

Zhou, Jun, et al. "CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer Via Inhibiting AKT Phosphorylation." Mol Ther Oncolytics 2020.